Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Platinum-Treated Extensive Stage Small Cell Lung Cancer
NCT00068289Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2003
- Modality
- Small Molecules, Modified Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of bortezomib in small cell lung cancer (SCLC), sponsored by SWOG Cancer Research Network. Started Sep 2003; status: completed.
02
Drugs
bortezomib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00068289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068289.